PAPER Taverna M, Straub T, Hampel H, Rujescu D, Lichtenthaler SF
SEARCH RESULTS
331009 RESULTS
PAPER Cheng X, Zhou Y, Gu W, Wu J, Nie A, Cheng J, Zhou J, Zhou W, Zhang Y
The Selective BACE1 Inhibitor VIa Reduces Amyloid-β Production in Cell and Mouse Models of Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;37(4):823-34. PubMed: 23948917PAPER Krako N, Magnifico MC, Arese M, Meli G, Forte E, Lecci A, Manca A, Giuffrè A, Mastronicola D, Sarti P, Cattaneo A
Characterization of Mitochondrial Dysfunction in the 7PA2 Cell Model of Alzheimer's Disease.
J Alzheimers Dis. 2013 Jan 1;37(4):747-58. PubMed: 23948918PAPER Chaunu MP, Deramecourt V, Buée-Scherrer V, Le Ber I, Brice A, Ehrle N, El Hachimi K, Pluot M, Maurage CA, Bakchine S, Buée L
Juvenile Frontotemporal Dementia with Parkinsonism Associated with Tau Mutation G389R.
J Alzheimers Dis. 2013 Jan 1;37(4):769-76. PubMed: 23948919PAPER Kim J, Jeong Y
Augmentation of Sensory-Evoked Hemodynamic Response in an Early Alzheimer's Disease Mouse Model.
J Alzheimers Dis. 2013 Jan 1;37(4):857-68. PubMed: 23948921PAPER Chamard L, Wallon D, Pijoff A, Berger E, Viennet G, Hannequin D, Magnin E
Amyloid-related imaging abnormalities in AβPP duplication carriers.
J Alzheimers Dis. 2013;37(4):789-93. PubMed: 23948920PAPER Carvalho C, Katz PS, Dutta S, Katakam PV, Moreira PI, Busija DW
Increased Susceptibility to Amyloid-β Toxicity in Rat Brain Microvascular Endothelial Cells under Hyperglycemic Conditions.
J Alzheimers Dis. 2014 Jan 1;38(1):75-83. PubMed: 23948922PAPER Yener GG, Kurt P, Emek DD, Güntekin B, Başar E
Reduced Visual Event-Related Delta Oscillatory Responses in Amnestic Mild Cognitive Impairment.
J Alzheimers Dis. 2013 Aug 2; PubMed: 23948923PAPER Cano-Cuenca N, Solís-García Del Pozo JE, Jordán J
Evidence for the Efficacy of Latrepirdine (Dimebon) Treatment for Improvement of Cognitive Function: A Meta-Analysis.
J Alzheimers Dis. 2014 Jan 1;38(1):155-64. PubMed: 23948924PAPER Borghys H, Jacobs T, Van Broeck B, Dillen L, Dhuyvetter D, Gijsen H, Mercken M
Comparison of Two Different Methods for Measurement of Amyloid-β Peptides in Cerebrospinal Fluid after BACE1 Inhibition in a Dog Model.
J Alzheimers Dis. 2014 Jan 1;38(1):39-48. PubMed: 23948925PAPER Yu Y, Liu J, Li SQ, Peng L, Ye RD
Serum Amyloid A Differentially Activates Microglia and Astrocytes via the PI3K Pathway.
J Alzheimers Dis. 2014 Jan 1;38(1):133-44. PubMed: 23948927PAPER Shi J, Han P, Kuniyoshi SM
Cognitive Impairment in Neurological Diseases: Lessons from Apolipoprotein E.
J Alzheimers Dis. 2013 Aug 2; PubMed: 23948926PAPER Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I
Using cerebrospinal fluid marker profiles in clinical diagnosis of dementia with Lewy bodies, Parkinson's disease, and Alzheimer's disease.
J Alzheimers Dis. 2014;38(1):63-73. PubMed: 23948928PAPER Lee L, Kosuri P, Arancio O
Picomolar Amyloid-β Peptides Enhance Spontaneous Astrocyte Calcium Transients.
J Alzheimers Dis. 2014 Jan 1;38(1):49-62. PubMed: 23948929PAPER Nguyen HT, Sawmiller DR, Markovb O, Chen M
Elevated [Ca2+]i Levels Occur with Decreased Calpain Activity in Aged Fibroblasts and Reversal by Energy-Rich Compounds: Implications for Alzheimer's Disease Prevention.
J Alzheimers Dis. 2013 Aug 2; PubMed: 23948930Current Filters
No filters selected